Ricardo Ribeiro Alves Fernandes

3PUBLICATIONS
7CO-AUTHORS
NanomedicineHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 10, 2025
Nivolumab and pembrolizumab in the treatment of metastatic melanoma: a retrospective budget impact analysis from the perspective of the Brazilian National Health System, Brazil, 2019-2022.

Ricardo Ribeiro Alves Fernandes, Keitty Regina Cordeiro de Andrade, Ivan Ricardo Zimmermann

|Sep 19, 2019
[Economic assessment of dexrazoxane in prophylaxis of cardiotoxicity in children undergoing chemotherapy with anthracyclines].

Ricardo Ribeiro Alves Fernandes, Cid Manso de Mello Vianna, Paulo Gomes de Freitas

|Jul 05, 2019
Target therapy versus dacarbazine in first-line treatment of advanced non-surgical and metastatic melanoma: budget impact analysis from the perspective of the Brazilian National Health System, 2018-2020.

Flávia de Miranda Corrêa, Renata Leborato Guerra, Ricardo Ribeiro Alves Fernandes

Pageof 1